ArticleMaternal and child health journal2017
Screening for and Treating Postpartum Depression and Psychosis: A Cost-Effectiveness Analysis.
Article in Maternal and child health journal, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 7 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
42 citing papers in PubMed, 7 syntheses or guidelines pooled it, 95 citations in OpenAlex.
- Cost Effectiveness of Interventions for Perinatal Anxiety and/or Depression: A Systematic Review of Global Evidence.Applied health economics and health policy · 2026Pooled it
- A systematic review of postpartum psychosis resulting in infanticide: missed opportunities in screening, diagnosis, and treatment.Archives of women's mental health · 2025Pooled it
- Screening programs for common maternal mental health disorders among perinatal women: report of the systematic review of evidence.BMC psychiatry · 2022Pooled it
- Recovery from postpartum psychosis: a systematic review and metasynthesis of women's and families' experiences.Archives of women's mental health · 2020Pooled it
- Economic burden of maternal morbidity - A systematic review of cost-of-illness studies.PloS one · 2020Pooled it
- Cost-effectiveness of interventions for perinatal anxiety and/or depression: a systematic review.BMJ open · 2018Pooled it
- Economic evaluation of screening, treatment, and prevention interventions for perinatal mood and anxiety disorders: a systematic review.General hospital psychiatryPooled it
- Effects of participation in a U.S. trial of newborn genomic sequencing on parents at risk for depression.Journal of genetic counseling · 2022Trial
- The positive effect of mother-performed infant massage on infantile eczema and maternal mental state: A randomized controlled trial.Frontiers in public health · 2022Trial
- Cost-effectiveness of virtual Mindfulness-Based Cognitive Therapy on pregnancies at high risk of perinatal depression.Pregnancy (Hoboken, N.J.) · 2026Article
- Article
- Cost-effectiveness of short-term parent-infant-psychotherapy, results from two randomized controlled trials.Cost effectiveness and resource allocation : C/E · 2025Article
- Diagnosis of postpartum depression and associated factors in South Africa: a cohort study of 47,697 women.Epidemiology and psychiatric sciences · 2025Article
- Article
- Opioid analgesic and antidepressant use during pregnancy and the risk of spontaneous preterm birth: A nested case-control study.Paediatric and perinatal epidemiology · 2025Article
- Article
- Empowering new mothers in China: role of paediatric care in screening and management of postpartum depression.BMJ (Clinical research ed.) · 2024Article
- A scoping review of costing methodologies used to assess interventions for underserved pregnant people and new parents.International journal for equity in health · 2024Article
- Societal costs of untreated perinatal mood and anxiety disorders in Vermont.Archives of women's mental health · 2024Article
- Health economic evaluations of preventative care for perinatal anxiety and associated disorders: a rapid review.BMJ open · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
Abstract
Objectives Postpartum depression impacts 6.5-12.9% of U.S. women. Postpartum depression is associated with impaired bonding and development, marital discord, suicide, and infanticide. However, the current standard of care is to not screen women for postpartum depression. This study modeled the cost-effectiveness of physicians screening for and treating postpartum depression and psychosis in partnership with a psychiatrist. Methods This study follows a hypothetical cohort of 1000 pregnant women experiencing one live birth over a 2-year time horizon. We used a decision tree model to obtain the outcomes of screening for and treating postpartum depression and psychosis using the Edinburgh Postnatal Depression Scale. We use a Medicaid payer perspective because they cover approximately 50% of births in the U.S. The cost-effectiveness of the intervention is measured in cost per remission achieved and cost per quality-adjusted life-year (QALY) gained. We conducted both deterministic and probabilistic sensitivity analyses. Results Screening for and treating postpartum depression and psychosis produced 29 more healthy women at a cost of $943 per woman. The incremental cost-effectiveness ratios of the intervention branch compared to usual care were $13,857 per QALY gained (below the commonly accepted willingness to pay threshold of $50,000/QALY gained) and $10,182 per remission achieved. These results were robust in both the deterministic and probabilistic sensitivity analyses of input parameters. Conclusions for Practice Screening for and treating postpartum depression is a cost-effective intervention and should be considered as part of usual postnatal care, which aligns with the recently proposed recommendations from the U.S. Preventive Services Task Force.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.